← Back to Search

Antiplatelet Agent

Clopidogrel (Plavix®) and PA32540 for Platelet Aggregation

Phase 1
Waitlist Available
Research Sponsored by POZEN
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 days
Awards & highlights
All Individual Drugs Already Approved
Approved for 10 Other Conditions
No Placebo-Only Group

Summary

This study is designed to provide data on platelet aggregation of PA32540 plus clopidogrel dosed separately compared to EC aspirin 81 mg plus EC omeprazole 40 mg plus clopidogrel dosed concomitantly.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Evaluate adenosine diphosphate (ADP)-induced platelet aggregation
Secondary study objectives
Evaluate arachidonic acid (AA)-induced platelet aggregation

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Approved for 10 Other Conditions
This treatment demonstrated efficacy for 10 other conditions.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Clopidogrel (Plavix®) and PA32540Experimental Treatment1 Intervention
PA32540 and Clopidogrel (Plavix®) tablet, 10 hours post PA32540
Group II: EC aspirin, EC omeprazole, ClopidogrelActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Clopidogrel
FDA approved

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

POZENLead Sponsor
29 Previous Clinical Trials
8,154 Total Patients Enrolled
Lisa ZimmermanStudy DirectorPOZEN
~2 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top